Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm

Trial Profile

Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2017

At a glance

  • Drugs Sodium nitrite (Primary)
  • Indications Subarachnoid haemorrhage
  • Focus Therapeutic Use
  • Sponsors Hope Pharmaceuticals
  • Most Recent Events

    • 09 May 2017 Status changed from recruiting to discontinued.
    • 26 Feb 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
    • 21 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top